<SUBMISSION>
<SECRELEASE-DATETIME> 20240205-195346 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20240205-195345 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20240205-195324 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001104659-24-010817
<TYPE> SC 13D/A
<PUBLIC-DOCUMENT-COUNT> 1
<FILING-DATE> 20240205
<DATE-OF-FILING-DATE-CHANGE> 20240205
|
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME> NAVIDEA BIOPHARMACEUTICALS, INC.
<CIK> 0000810509
<ASSIGNED-SIC> 2835
<ORGANIZATION-NAME> 03 Life Sciences
<IRS-NUMBER> 311080091 ⇒ 31-1080091 or 311-08-0091
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC 13D/A
<ACT> 34
<FILE-NUMBER> 005-43603
<FILM-NUMBER> 24597683
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 4995 BRADENTON AVENUE
<STREET2> SUITE 240
<CITY> DUBLIN
<STATE> OH
<ZIP> 43017
<PHONE> 6147937500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 4995 BRADENTON AVENUE
<STREET2> SUITE 240
<CITY> DUBLIN
<STATE> OH
<ZIP> 43017
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> NEOPROBE CORP
<DATE-CHANGED> 19940714
</FORMER-COMPANY>
</SUBJECT-COMPANY>
|
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME> Scott John K Jr.
<CIK> 0001753763
<ORGANIZATION-NAME>
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC 13D/A
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1> 30 BLUE HERON DR.
<CITY> GREENWOOD VILLAGE
<STATE> CO
<ZIP> 80121
</MAIL-ADDRESS>
</FILED-BY>
|
<DOCUMENT>
<TYPE> SC 13D/A
<SEQUENCE> 1
<FILENAME> tm245286d1_sc13da.htm
<DESCRIPTION> SC 13D/A
<TEXT>
<HTML>
Show <HTML>: 381 lines (widest: 1,188 characters) - 33K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
